Citation Impact
Citing Papers
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes
2006 StandoutNobel
Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances: II
1992
The Urine Sediment as a Biomarker of Kidney Disease
2015
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations
2007 Standout
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
1996 Standout
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
2019
Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use
2015
Effects of Low Habitual Cocoa Intake on Blood Pressure and Bioactive Nitric Oxide
2007
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
2000 Standout
Traumatic brain injury
2000 Standout
Oral Antihyperglycemic Therapy for Type 2 Diabetes
2002
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies
2010
Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances. I
1991
Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria
1992
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Changes in causes of death in systemic sclerosis, 1972–2002
2007 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction
2018
Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference
2013
Acute kidney injury
2019 Standout
The effect of graded hypertonia on interstitial volume, tissue resistance and synaptic transmission in rat hippocampal tissue slices
1995
Nonketotic hypertonicity in diabetes mellitus
1995
Scleroderma renal crisis
2003
Curcumin: The story so far
2005 Standout
Acute kidney injury
2021 Standout
Microfluidic organs-on-chips
2014 Standout
Drug-Induced Diarrhoea
2000
Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults
2017
Southwestern Internal Medicine Conference: Hyperosmolar States
1990
Outcome of Renal Crisis in Systemic Sclerosis: Relation to Availability of Angiotensin Converting Enzyme (ACE) Inhibitors
1990
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
The present and future role of microfluidics in biomedical research
2014 StandoutNature
Furosemide (Frusemide)
1990
The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?
2014
Type 2 diabetes mellitus
2015 Standout
Hypernatremia
2000 Standout
CURRENT TRENDS IN THE MANAGEMENT OF HEAD INJURY
1998
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Osmotic Demyelination Syndrome after Correction of Chronic Hyponatremia with Normal Saline
2002
Kidney injury molecule-1
2010
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Synthesis and optimization of picolinamide derivatives as a novel class of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors
2015
Chronic Kidney Disease
2016 Standout
Antibiotic-Associated Diarrhea
2002 Standout
IgE, mast cells, basophils, and eosinophils
2010 Standout
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Disorders of Water Balance
1979
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Platelet Cytosolic Ca 2+ and Membrane Dynamics in Patients With Primary Hypercholesterolemia
1995
Urticaria and Angioedema
1979
Angiotensin-Converting Enzyme Inhibition and Renal Protection
1993
Hyperkalemia: A Review
2005
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
The gastrointestinal manifestations of scleroderma: Pathogenesis and management
1980 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
2013 Standout
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Hypertonic Environment Prevents Depolarization and Improves Functional Recovery from Hypoxia in Hippocampal Slices
1996
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Pharmacology behind Common Drug Nephrotoxicities
2018
The mammalian central nervous synaptic cleft contains a high density of periodically organized complexes
2005 StandoutNobel
Nanomedicine(s) under the Microscope
2011
Hyperglycemic Crises in Adult Patients With Diabetes
2009 Standout
Clinical Pharmacokinetics of Hydralazine
1982
Management of Hyperglycemic Crises in Patients With Diabetes
2001
An Assessment of Insulin Action in Hyperosmolar Hyperglycemic Nonketotic Diabetic Patients
1985
A Biophysical Indicator of Vaso-occlusive Risk in Sickle Cell Disease
2012
Dynamics and Consequences of Potassium Shifts in Skeletal Muscle and Heart During Exercise
2000
Hyponatremia: A Prospective Analysis of Its Epidemiology and the Pathogenetic Role of Vasopressin
1985 Standout
Ischemic Cell Death in Brain Neurons
1999 Standout
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
11β-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects
2013
Subclinical Brain Swelling in Children during Treatment of Diabetic Ketoacidosis
1985
Electrochemical Glucose Sensors and Their Applications in Diabetes Management
2008 Standout
Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI)
2011
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Polyphenols and Human Health: The Role of Bioavailability
2021 Standout
Mechanisms of Renal Fibrosis
2017 Standout
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Alpha-glucosidase inhibitors for type 2 diabetes mellitus
2005
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Na(+)-H+ exchanger expression in vascular smooth muscle of spontaneously hypertensive and Wistar-Kyoto rats.
1994
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Works of Peter U. Feig being referenced
Increased Platelet Membrane Sodium-Proton Exchange Rate in Spontaneously Hypertensive Rats
1990
Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension
2011
Next-generation biomarkers for detecting kidney toxicity
2010
A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension
2006
Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist
1992
Angiotensin Converting Enzyme Inhibitors: The End of End-Stage Renal Disease?
1989
Cellular mechanism of action of loop diuretics: Implications for drug effectiveness and adverse effects
1986
Internal Potassium Balance and the Control of the Plasma Potassium Concentration
1981
Hypernatremia and Hypertonic Syndromes
1981
Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action
2017
Effect of Potassium Removal during Hemodialysis on the Plasma Potassium Concentration
1981
Drug Therapy in Renal Failure: Dosing Guidelines for Adults
1980
Drug Therapy in Renal Failure: Dosing Guidelines for Adults
1980
Control of Hypertension and Reversal of Renal Failure in Scleroderma
1978
The Hypertonic State
1977
Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition
1998
Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients
1998
Vasculitis With Urticaria, Hypocomplementemia, and Multiple System Involvement
1976